View in EDS HTML Full Text PDF Full Text

LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cells.

Saved in:
Bibliographic Details
Title: LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cells.
Authors: Serra-Bardenys G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Institut Bonanova FP Sanitaria, Consorci Mar Parc de Salut de Barcelona, Spain., Blanco E; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain., Escudero-Iriarte C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Serra-Camprubí Q; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Querol J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Pascual-Reguant L; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain., Morancho B; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Escorihuela M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Tissera NS; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Sabé A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Martín L; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Segura-Bayona S; The Francis Crick Institute, London, UK., Verde G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Aiese Cigliano R; Sequentia Biotech SL, Barcelona, Spain., Millanes-Romero A; Institute for Research in Biomedicine (IRB Barcelona) and Barcelona Institute of Science and Technology, Spain., Jerónimo C; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Institut de Recherches Cliniques de Montréal, Canada., Cebrià-Costa JP; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Nuciforo P; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Simonetti S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Viaplana C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Oliveira M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Peg V; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Barcelona, Spain.; Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain., Stracker TH; Radiation Oncology Branch, National Cancer Institute, Bethesda, MD, USA., Arribas J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Canals F; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Villanueva J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Di Croce L; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., García de Herreros A; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain., Tian TV; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Peiró S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Source: The FEBS journal [FEBS J] 2024 Jun; Vol. 291 (11), pp. 2423-2448. Date of Electronic Publication: 2024 Mar 07.
Publication Type: Journal Article
Journal Info: Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-4658 (Electronic) Linking ISSN: 1742464X NLM ISO Abbreviation: FEBS J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38451841
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Serra-Bardenys+G%22">Serra-Bardenys G</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Institut Bonanova FP Sanitaria, Consorci Mar Parc de Salut de Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Blanco+E%22">Blanco E</searchLink>; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.<br /><searchLink fieldCode="AU" term="%22Escudero-Iriarte+C%22">Escudero-Iriarte C</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Serra-Camprubí+Q%22">Serra-Camprubí Q</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Querol+J%22">Querol J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pascual-Reguant+L%22">Pascual-Reguant L</searchLink>; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.<br /><searchLink fieldCode="AU" term="%22Morancho+B%22">Morancho B</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Escorihuela+M%22">Escorihuela M</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tissera+NS%22">Tissera NS</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sabé+A%22">Sabé A</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Martín+L%22">Martín L</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Segura-Bayona+S%22">Segura-Bayona S</searchLink>; The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Verde+G%22">Verde G</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Aiese+Cigliano+R%22">Aiese Cigliano R</searchLink>; Sequentia Biotech SL, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Millanes-Romero+A%22">Millanes-Romero A</searchLink>; Institute for Research in Biomedicine (IRB Barcelona) and Barcelona Institute of Science and Technology, Spain.<br /><searchLink fieldCode="AU" term="%22Jerónimo+C%22">Jerónimo C</searchLink>; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Institut de Recherches Cliniques de Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Cebrià-Costa+JP%22">Cebrià-Costa JP</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Nuciforo+P%22">Nuciforo P</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Simonetti+S%22">Simonetti S</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Viaplana+C%22">Viaplana C</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Dienstmann+R%22">Dienstmann R</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Oliveira+M%22">Oliveira M</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Peg+V%22">Peg V</searchLink>; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Barcelona, Spain.; Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain.<br /><searchLink fieldCode="AU" term="%22Stracker+TH%22">Stracker TH</searchLink>; Radiation Oncology Branch, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Arribas+J%22">Arribas J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Canals+F%22">Canals F</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villanueva+J%22">Villanueva J</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Di+Croce+L%22">Di Croce L</searchLink>; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García+de+Herreros+A%22">García de Herreros A</searchLink>; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tian+TV%22">Tian TV</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Peiró+S%22">Peiró S</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101229646%22">The FEBS journal</searchLink> [FEBS J] 2024 Jun; Vol. 291 (11), pp. 2423-2448. <i>Date of Electronic Publication: </i>2024 Mar 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+by+Blackwell+Pub%2E+on+behalf+of+the+Federation+of+European+Biochemical+Societies%22">Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101229646 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1742-4658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221742464X%22">1742464X </searchLink><i>NLM ISO Abbreviation: </i>FEBS J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38451841
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/febs.17112
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2423
    Titles:
      – TitleFull: LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Serra-Bardenys G
      – PersonEntity:
          Name:
            NameFull: Blanco E
      – PersonEntity:
          Name:
            NameFull: Escudero-Iriarte C
      – PersonEntity:
          Name:
            NameFull: Serra-Camprubí Q
      – PersonEntity:
          Name:
            NameFull: Querol J
      – PersonEntity:
          Name:
            NameFull: Pascual-Reguant L
      – PersonEntity:
          Name:
            NameFull: Morancho B
      – PersonEntity:
          Name:
            NameFull: Escorihuela M
      – PersonEntity:
          Name:
            NameFull: Tissera NS
      – PersonEntity:
          Name:
            NameFull: Sabé A
      – PersonEntity:
          Name:
            NameFull: Martín L
      – PersonEntity:
          Name:
            NameFull: Segura-Bayona S
      – PersonEntity:
          Name:
            NameFull: Verde G
      – PersonEntity:
          Name:
            NameFull: Aiese Cigliano R
      – PersonEntity:
          Name:
            NameFull: Millanes-Romero A
      – PersonEntity:
          Name:
            NameFull: Jerónimo C
      – PersonEntity:
          Name:
            NameFull: Cebrià-Costa JP
      – PersonEntity:
          Name:
            NameFull: Nuciforo P
      – PersonEntity:
          Name:
            NameFull: Simonetti S
      – PersonEntity:
          Name:
            NameFull: Viaplana C
      – PersonEntity:
          Name:
            NameFull: Dienstmann R
      – PersonEntity:
          Name:
            NameFull: Oliveira M
      – PersonEntity:
          Name:
            NameFull: Peg V
      – PersonEntity:
          Name:
            NameFull: Stracker TH
      – PersonEntity:
          Name:
            NameFull: Arribas J
      – PersonEntity:
          Name:
            NameFull: Canals F
      – PersonEntity:
          Name:
            NameFull: Villanueva J
      – PersonEntity:
          Name:
            NameFull: Di Croce L
      – PersonEntity:
          Name:
            NameFull: García de Herreros A
      – PersonEntity:
          Name:
            NameFull: Tian TV
      – PersonEntity:
          Name:
            NameFull: Peiró S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2024 Jun
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1742-4658
          Numbering:
            – Type: volume
              Value: 291
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: The FEBS journal
              Type: main
ResultId 1